|
Rare disease consultation to launch |
Plans for a European Commission consultation on the future of the treatment of rare diseases have been unveiled at a conference in Lisbon, Portugal.
The European Organisation for Rare Diseases (Eurodis), which organised the event to discuss topics concerning the millions of people living with unusual medical conditions, said that it had helped contribute to the creation of a new European Union Communication designed to help countries form policies to deal with rare diseases. |
|
Read more...
|
|
|
Access to drugs in developing world 'needs precise solutions' |
An organisation representing drug makers has once again highlighted the need for patients in the developing world to have proper access to medications.
Ensuring that people around the world can be given appropriate medications when required is an essential part of the World Health Organisation's objectives, with the organisation assembling its own intergovernmental working group on the issue of "addressing unmet developing world health needs: sustainable, practical solutions". |
|
Read more...
|
|
|
Counterfeit drugs threaten global health |
|
Masters has produced a white paper discussing threat posed to global health by counterfeit medicines. An executive summary of the document is given here, and the full document is available as a download at the end of this summary.
|
|
Read more...
|
|
|
Managing named-patient programmes |
|
Project managing a named-patient programme can be time-consuming and complex. Many pharmaceutical companies choose to outsource the management of the supply of their drug to a specialist third party company who are considered experts in controlling the supply of medicines on a named-patient basis.
|
|
Read more...
|
|
|